TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.
Also called NCT02310100
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 178 participants
- Sponsor
- Registry
-
NCT02310100
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02310100. Allocation not applicable; no masking; primary purpose treatment. Start 2015-01-21 (actual); primary completion 2017-02 (actual). Results posted on 2019-03-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
- Acronym
- TactiCathPAS
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- TactiCath Quartz treatment
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02310100- Content hash
ffa17cf2fef4c5de8e09e25efc49d2fa109a39bbb63da6e60e954525e5a68b8a